Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data

RM Islam, RJ Bell, S Green, MJ Page… - The lancet Diabetes & …, 2019 - thelancet.com
Background The benefits and risks of testosterone treatment for women with diminished
sexual wellbeing remain controversial. We did a systematic review and meta-analysis to …

Testosterone in women—the clinical significance

SR Davis, S Wahlin-Jacobsen - The lancet Diabetes & …, 2015 - thelancet.com
Testosterone is an essential hormone for women, with physiological actions mediated
directly or via aromatisation to oestradiol throughout the body. Despite the crucial role of …

Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline

ME Wierman, W Arlt, R Basson, SR Davis… - The Journal of …, 2014 - academic.oup.com
Objective: To update practice guidelines for the therapeutic use of androgens in women.
Participants: A Task Force appointed by the Endocrine Society, American Congress of …

Postmenopausal hormone therapy: an Endocrine Society scientific statement

RJ Santen, DC Allred, SP Ardoin… - The Journal of …, 2010 - academic.oup.com
Objective: Our objective was to provide a scholarly review of the published literature on
menopausal hormonal therapy (MHT), make scientifically valid assessments of the available …

[HTML][HTML] Hypoactive sexual desire disorder: International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review

I Goldstein, NN Kim, AH Clayton, LR DeRogatis… - Mayo clinic …, 2017 - Elsevier
The objective of the International Society for the Study of Women's Sexual Health expert
consensus panel was to develop a concise, clinically relevant, evidence-based review of the …

[HTML][HTML] The International Society for the Study of Women's Sexual Health process of care for management of hypoactive sexual desire disorder in women

AH Clayton, I Goldstein, NN Kim, SE Althof… - Mayo Clinic …, 2018 - Elsevier
Abstract The International Society for the Study of Women's Sexual Health process of care
(POC) for management of hypoactive sexual desire disorder (HSDD) algorithm was …

Mechanisms in endocrinology: medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions

E Nieschlag, E Vorona - European journal of endocrinology, 2015 - academic.oup.com
Anabolic androgenic steroids (AASs) are appearance and performance-enhancing drugs
(APEDs) used in competitive athletics, in recreational sports, and by body-builders. The …

The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation

A Finch, KA Metcalfe, JK Chiang, L Elit… - Gynecologic …, 2011 - Elsevier
OBJECTIVE: Prophylactic salpingo-oophorectomy is recommended to women who carry a
BRCA1 or BRCA2 mutation to reduce the risks of breast, ovarian and fallopian tube cancer …

Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled …

SR Davis, MJ Van Der Mooren, RHW van Lunsen… - Menopause, 2006 - journals.lww.com
Objective: Evaluation of the use of testosterone therapy for hypoactive sexual desire
disorder (HSDD) after oophorectomy has mostly involved women treated with oral estrogen …

Androgens and female sexual function and dysfunction—findings from the Fourth International Consultation of Sexual Medicine

SR Davis, R Worsley, KK Miller… - The journal of sexual …, 2016 - academic.oup.com
Introduction Androgens have been implicated as important for female sexual function and
dysfunction. Aim To review the role of androgens in the physiology and pathophysiology of …